-
Decluttering Complexity: A Pragmatic Framework for Simplifying Global Health Economic Models for HTA
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole for the Treatment of Invasive Aspergillosis in Morocco
Sep 9, 2025, 16:22 PM -
Analysis of Changes in ICER Accepted for Drug Reimbursement After the Introduction of Positive List System in South Korea: 2007-2021
Sep 9, 2025, 16:22 PM -
Impact of Individualized Neoantigen Therapies on Health, Productivity, and Health System Capacity Outcomes in Resected Melanoma in Belgium
Sep 9, 2025, 16:22 PM -
Economic Burden of COPD in Algeria: A Retrospective Analysis of Healthcare Resource Utilization and Costs
Sep 9, 2025, 16:22 PM -
Cost of Adverse Events With the Bruton Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib in the First-Line Treatment of Chronic Lymphocytic Leukemia in Brazil
Sep 9, 2025, 16:22 PM -
Association Between Invasive Disease-Free Survival/Distant Recurrence-Free Survival and Overall Survival in Patients With Early Stage Triple-Negative Breast Cancer
Sep 9, 2025, 16:22 PM -
Flexible Parametric Inference for Cause-Specific Hazard-Competing Risk Models Under Interval Censoring
Sep 9, 2025, 16:22 PM -
Identifying CKD As a Key Driver of CVD Deaths
Sep 9, 2025, 16:22 PM -
From French Early Access to Regular Reimbursement: How Do Prices Shift Post-HTA?
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Early Scientific Advice Mechanisms: EU JSC vs. National HTA Bodies (HAS, G-BA, NICE)
Sep 9, 2025, 16:22 PM -
Survival Model Uncertainty in Economic Modeling: Evaluating Bootstrap and Cholesky Decomposition Methods
Sep 9, 2025, 16:22 PM -
EQ-5D Utility Trends in NMOSD: Impact of Time and Disability
Sep 9, 2025, 16:22 PM -
Comparative Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole for the Treatment of Invasive Aspergillosis in Algerian Hospital Setting
Sep 9, 2025, 16:22 PM -
Healthcare Burden Among Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Facilitating Investment in Obesity Care and Prevention: A Societal Cost Benefit Analysis for the Netherlands
Sep 9, 2025, 16:22 PM -
Hospital Community Integration: The Case of the Territorial Oncology Center at ASL 04 Teramo
Sep 9, 2025, 16:22 PM -
Including Decision Uncertainty About the Clinically Minimal Important Difference: Shifting From Risk Aversion to Risk Awareness in Drug Reimbursement Processes
Sep 9, 2025, 16:22 PM -
Bridging the Access Gap: The Role of Non-Public Access Partnerships for Oncology Treatments in China
Sep 9, 2025, 16:22 PM -
Utilization and Expenditures of Medications Withdrawn From Markets Due to Safety Concerns in China
Sep 9, 2025, 16:22 PM